Latest filing published 23 Jan 2026 for JB Chemicals & Pharmaceuticals Limited, €3.2M.
Filing timeline
BuySaleKunal Anil Khanna: trading record in brief
Kunal Anil Khanna discloses dealings in JB Chemicals & Pharmaceuticals Limited to SEBI (PIT + SAST). Over a trading history stretching from 21 January 2026 to 23 January 2026, the count stands at 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 23 January 2026 came the latest disclosure, a transaction for €3.2M in JB Chemicals & Pharmaceuticals Limited. Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Companies and markets linked to Kunal Anil Khanna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 217,534 shares@ ₹1,600.0023.9% of flowEquity SharesSEBI:2a1a027ef10ce0abd56033882368f5f6404ef5e6
- 217,534 shares@ ₹1,600.0023.9% of flowEquity SharesSEBI:f37e3fd3e2dce4174cc15fcd3da55c32e25f3a93
- 217,534 shares@ ₹1,600.0023.9% of flowEquity SharesSEBI:dae40d646b6b1181ba0b00964e82947ad2650a01
- 217,540 shares@ ₹1,884.6028.3% of flowEquity SharesSEBI:5bcb4a307a3ac0fccd37182aaae2d0c51e446db2Canonical exit: 21 Apr 2026 (T+90)
4 of 4 declarations
